EDG3 and SHC3 on chromosome 9q22 are co-amplified in human ependymomas

Cancer Lett. 2010 Apr 1;290(1):36-42. doi: 10.1016/j.canlet.2009.08.023. Epub 2009 Sep 12.

Abstract

By qPCR we found that EDG3 and SHC3 were amplified in 60% of ependymomas but none in choroid plexus papillomas. In ependymomas EDG3 and SHC3 amplification increased Shc3 protein levels while EDG3 was less affected. Both proteins were co-immunoprecipitated from ependymoma and Shc3 was tyrosine phosphorylated thus presumably active. We showed by digestion with N-glycosidase-F that EDG3 was glycosylated indicating that EDG3 protein was not retained in the endoplasmic reticulum. The co-immunoprecipitation of Shc3 and EDG3 proteins from ependymomas with amplification of SHC3 and EDG3 genes suggests that the two proteins co-operate and are important for ependymomas in vivo.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blotting, Western
  • Chromosomes, Human, Pair 9 / genetics*
  • Ependymoma / genetics*
  • Gene Amplification
  • Humans
  • Immunohistochemistry
  • Immunoprecipitation
  • In Situ Hybridization, Fluorescence
  • Polymerase Chain Reaction
  • Receptors, Lysosphingolipid / genetics*
  • Shc Signaling Adaptor Proteins / genetics*
  • Src Homology 2 Domain-Containing, Transforming Protein 3

Substances

  • Receptors, Lysosphingolipid
  • SHC3 protein, human
  • Shc Signaling Adaptor Proteins
  • Src Homology 2 Domain-Containing, Transforming Protein 3